
Paul Martens Janeski
Examiner (ID: 4040, Phone: (571)270-1681 , Office: P/3722 )
| Most Active Art Unit | 3722 |
| Art Unit(s) | 3726, 3722 |
| Total Applications | 635 |
| Issued Applications | 463 |
| Pending Applications | 0 |
| Abandoned Applications | 175 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16791729
[patent_doc_number] => 20210121546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => COMPOSITION OF TUMOR-ASSOCIATED PROLIFERATIVE PEPTIDES AND RELATED ANTI-CANCER IMMUNOGEN FOR THE TREATMENT OF LUNG CANCERS AND OTHER CANCERS
[patent_app_type] => utility
[patent_app_number] => 16/640988
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16640988
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/640988 | Composition of tumor-associated proliferative peptides and related anti-cancer immunogen for the treatment of lung cancers and other cancers | Aug 20, 2018 | Issued |
Array
(
[id] => 13618781
[patent_doc_number] => 20180360942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => ATTENUATED VACCINES TO PROTECT AGAINST TICK-BORNE EHRLICHIA SPECIES INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/106546
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16106546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/106546 | Attenuated vaccines to protect against tick-borne | Aug 20, 2018 | Issued |
Array
(
[id] => 17103224
[patent_doc_number] => 11123415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Nanoparticle compositions for
[patent_app_type] => utility
[patent_app_number] => 16/639311
[patent_app_country] => US
[patent_app_date] => 2018-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 57
[patent_no_of_words] => 17873
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16639311
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/639311 | Nanoparticle compositions for | Aug 15, 2018 | Issued |
Array
(
[id] => 16087029
[patent_doc_number] => 20200197501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => RABBIT COCCIDIOSIS VACCINE AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/488034
[patent_app_country] => US
[patent_app_date] => 2018-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488034
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488034 | Rabbit coccidiosis vaccine and application thereof | Aug 9, 2018 | Issued |
Array
(
[id] => 14040819
[patent_doc_number] => 20190076516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => IMMUNOGENIC COMPOSITION FOR USE IN VACCINATION AGAINST STAPHYLOCOCCI
[patent_app_type] => utility
[patent_app_number] => 16/046505
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16046505
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/046505 | Immunogenic composition for use in vaccination against staphylococci | Jul 25, 2018 | Issued |
Array
(
[id] => 15814001
[patent_doc_number] => 10632157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Microbial compositions and methods of use for improving fowl production
[patent_app_type] => utility
[patent_app_number] => 16/042369
[patent_app_country] => US
[patent_app_date] => 2018-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 70698
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16042369
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/042369 | Microbial compositions and methods of use for improving fowl production | Jul 22, 2018 | Issued |
Array
(
[id] => 17921624
[patent_doc_number] => 11464845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/632278
[patent_app_country] => US
[patent_app_date] => 2018-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 22
[patent_no_of_words] => 19306
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632278 | None | Jul 19, 2018 | Issued |
Array
(
[id] => 13554801
[patent_doc_number] => 20180328948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => COMPOSITIONS USEFUL IN THE DIAGNOSTIC OF LATENTLY INFECTED MYCOBACTERIUM TUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 16/037150
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16037150
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/037150 | Compositions useful in the diagnostic of latently infected | Jul 16, 2018 | Issued |
Array
(
[id] => 15130095
[patent_doc_number] => 10478484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-19
[patent_title] => GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by
[patent_app_type] => utility
[patent_app_number] => 16/024145
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 25946
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16024145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/024145 | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by | Jun 28, 2018 | Issued |
Array
(
[id] => 17350004
[patent_doc_number] => 11224622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Agent for preventing or treating fat-associated diseases and/or inflammation
[patent_app_type] => utility
[patent_app_number] => 16/621650
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 9217
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16621650
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/621650 | Agent for preventing or treating fat-associated diseases and/or inflammation | Jun 14, 2018 | Issued |
Array
(
[id] => 16072955
[patent_doc_number] => 20200190464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => NOVEL LACTOBACILLUS HAVING ANTIVIRAL EFFECT AND COMPOSITION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/632508
[patent_app_country] => US
[patent_app_date] => 2018-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632508
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632508 | NOVEL LACTOBACILLUS HAVING ANTIVIRAL EFFECT AND COMPOSITION THEREOF | Jun 11, 2018 | Abandoned |
Array
(
[id] => 17569940
[patent_doc_number] => 11318194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => Vaccine against necrotic enteritis in poultry
[patent_app_type] => utility
[patent_app_number] => 16/616619
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 19
[patent_no_of_words] => 10542
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616619
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616619 | Vaccine against necrotic enteritis in poultry | May 30, 2018 | Issued |
Array
(
[id] => 16072953
[patent_doc_number] => 20200190463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => METHOD OF GENERATION BACTERIAL COMPOSITIONS COMPRISING A BIOFILM WITH BENEFECIAL BACTERIA
[patent_app_type] => utility
[patent_app_number] => 16/618137
[patent_app_country] => US
[patent_app_date] => 2018-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618137
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/618137 | METHOD OF GENERATION BACTERIAL COMPOSITIONS COMPRISING A BIOFILM WITH BENEFECIAL BACTERIA | May 28, 2018 | Abandoned |
Array
(
[id] => 16190810
[patent_doc_number] => 20200231659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => NANOBODIES AGAINST CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) INHIBITORY FACTOR (Cif)
[patent_app_type] => utility
[patent_app_number] => 16/616930
[patent_app_country] => US
[patent_app_date] => 2018-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616930
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616930 | Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif) | May 28, 2018 | Issued |
Array
(
[id] => 16604787
[patent_doc_number] => 10905771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Anti-MUC18 human immunotoxin and applications thereof
[patent_app_type] => utility
[patent_app_number] => 15/990668
[patent_app_country] => US
[patent_app_date] => 2018-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10171
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990668
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/990668 | Anti-MUC18 human immunotoxin and applications thereof | May 26, 2018 | Issued |
Array
(
[id] => 15553527
[patent_doc_number] => 20200061175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => IMMUNOGENS OBTAINED FROM PLASMODIUM YOELII USING QUANTITATIVE SEQUENCELINKAGE GROUP SELECTION METHOD
[patent_app_type] => utility
[patent_app_number] => 16/612686
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612686
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612686 | IMMUNOGENS OBTAINED FROM PLASMODIUM YOELII USING QUANTITATIVE SEQUENCELINKAGE GROUP SELECTION METHOD | May 10, 2018 | Abandoned |
Array
(
[id] => 18014372
[patent_doc_number] => 11506661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Detection of serum anti-FadA antibodies and related diagnostic methods
[patent_app_type] => utility
[patent_app_number] => 15/970391
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10130
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15970391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/970391 | Detection of serum anti-FadA antibodies and related diagnostic methods | May 2, 2018 | Issued |
Array
(
[id] => 15895359
[patent_doc_number] => 20200147198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => Novel Multivalent Polysaccharide-Protein Conjugate Vaccine Composition and Formulation Thereof
[patent_app_type] => utility
[patent_app_number] => 16/625246
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625246
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625246 | Novel Multivalent Polysaccharide-Protein Conjugate Vaccine Composition and Formulation Thereof | Apr 25, 2018 | Abandoned |
Array
(
[id] => 15975681
[patent_doc_number] => 10668142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Injectable vaccines against multiple meningococcal serogroups
[patent_app_type] => utility
[patent_app_number] => 15/962507
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17459
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962507
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/962507 | Injectable vaccines against multiple meningococcal serogroups | Apr 24, 2018 | Issued |
Array
(
[id] => 17050706
[patent_doc_number] => 20210260140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => NOVEL LACTIC ACID BACTERIA AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/760689
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760689
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/760689 | Lactic acid bacteria and use thereof | Apr 18, 2018 | Issued |